Epidemiology and Antimicrobial Susceptibility Pattern of Uropathogens in Patients with the Community- and Hospital-Acquired Urinary Tract Infections at a Tertiary Hospital in Somalia

Background: Urinary tract infections (UTIs) are the most common infections in the community and in hospitalized patients. Objectives: To investigate the epidemiology and antimicrobial susceptibility pattern of uropathogens and determine the appropriate empirical antibiotics to treat UTIs in the community and hospitalized patients. Methods: A total of 2,485 urine cultures were performed at Mogadishu Somali Turkish Training and Research Hospital. Through the standard Kirby-Bauer disk diffusion method and commercial disks, antimicrobial sensitivity and resistance were studied based on the Clinical and Laboratory Standards Institute (CLSI) system using Mueller-Hinton agar. The identification of the microorganisms was done using eosin methylene blue agar and blood agar. Results: Escherichia coli was the most predominant pathogen (63.4%) in all age groups, both genders, and in the community and hospital-acquired UTIs, followed by Klebsiella pneumonia (13.3%). Ceftriaxone, trimethoprim/sulfamethoxazole, ampicillin, cefuroxime, and cefixime revealed the highest resistance level (82-100%) against uropathogens. Ciprofloxacin (67.7%) and levofloxacin (54.2%) showed increasing resistance rates against uropathogens. Tigecycline, colimycin, vancomycin, and teicoplanin exhibited the most powerful sensitivity rate (100%). Moreover, fosfomycin, nitrofurantoin, and amikacin manifested a significant sensitivity rate ranging from 86% - 95%. Acinetobacter baumannii was the most prevalent pathogen that belonged to multidrug- and extensively drug-resistant patterns in 69.1% of the samples. Escherichia coli and K. pneumonia showed similar multidrug-resistant patterns in 35.2% of the cases. Conclusions: The results indicated increased trends of antimicrobial resistance rate in trimethoprim/sulfamethoxazole (85.1%) and fluoroquinolones (61%) against E. coli that was higher than the recommended local resistance rate for empirical therapy (< 20% and < 10%, respectively). According to the results, using fosfomycin and nitrofurantoin are suggested for UTI empiric treatment, and other antibiotics should be prescribed carefully.

[1]  Fatima Hussein,et al.  Antibiotic resistance pattern of Escherichia coli isolates from outpatients with urinary tract infections in Somalia. , 2020, Journal of infection in developing countries.

[2]  R. Ranjbar,et al.  Prevalence of Antibiotic Resistance and Distribution of Virulence Factors in the Shiga Toxigenic Escherichia coli Recovered from Hospital Food , 2019, Jundishapur Journal of Microbiology.

[3]  M. Chawsheen,et al.  Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil. , 2019, Journal of infection and public health.

[4]  S. Bouzari,et al.  Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli , 2019, Molecular immunology.

[5]  E. Rahimi,et al.  Prevalence, identification of virulence factors, O-serogroups and antibiotic resistance properties of Shiga-toxin producing Escherichia coli strains isolated from raw milk and traditional dairy products , 2018, Antimicrobial Resistance & Infection Control.

[6]  E. Concia,et al.  Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections , 2017, Journal of chemotherapy.

[7]  J. Zahar,et al.  Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015. , 2017, Medecine et maladies infectieuses.

[8]  L. Silver.  Fosfomycin: Mechanism and Resistance. , 2017, Cold Spring Harbor perspectives in medicine.

[9]  E. Rahimi,et al.  Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties , 2017, Antimicrobial Resistance & Infection Control.

[10]  T. Hooton,et al.  Diagnosis, Treatment, and Prevention of Urinary Tract Infection , 2016, Microbiology spectrum.

[11]  M. D. Hogan,et al.  Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes , 2016, Chemotherapy.

[12]  M. P. Chlebicki,et al.  Urinary tract infections in adults. , 2016, Singapore medical journal.

[13]  S. Alkhateeb,et al.  The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones , 2016, Saudi medical journal.

[14]  F. Alokaily.  Saudi Medical Journal reforms 2015 , 2016, Saudi medical journal.

[15]  R. Mirnejad,et al.  Virulence Factors and O-Serogroups Profiles of Uropathogenic Escherichia Coli Isolated from Iranian Pediatric Patients , 2014, Iranian Red Crescent medical journal.

[16]  J. Rodríguez-Baño,et al.  Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  R. Ranjbar,et al.  Uropathogenic Escherichia coli in Iran: Serogroup distributions, virulence factors and antimicrobial resistance properties , 2013, Annals of Clinical Microbiology and Antimicrobials.

[18]  K. Roberts.  Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months , 2011, Pediatrics.

[19]  M. Bader,et al.  Management of Complicated Urinary Tract Infections in the Era of Antimicrobial Resistance , 2010, Postgraduate medicine.

[20]  Mohammed Shahid,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Etiology and Antibiotic Resistance Patterns of Community-acquired Urinary Tract Infections in J N M C Hospital Aligarh, India , 2022 .

[21]  C. Struve,et al.  Development of a Long-Term Ascending Urinary Tract Infection Mouse Model for Antibiotic Treatment Studies , 2000, Antimicrobial Agents and Chemotherapy.

[22]  T. C. White,et al.  The R467K Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Drug Resistance through Reduced Affinity , 2000, Antimicrobial Agents and Chemotherapy.

[23]  A. Schaeffer,et al.  Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  G. Antonelli.  Emerging new technologies in clinical virology. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.